2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Thymus Cancer
Thymus cancer, a rare malignancy originating in the thymus gland, presents unique challenges in cancer research due to its rarity and complex biology. As a critical component of the immune system, the thymus plays a crucial role in T-cell maturation and immune function. Current research focuses on understanding the genetic and molecular mechanisms underlying thymus cancer development, as well as identifying potential therapeutic targets. Immunotherapy, particularly checkpoint inhibitors, shows promise in treating thymic malignancies by enhancing the body's immune response against cancer cells. Additionally, advancements in precision medicine and targeted therapies offer hope for improved outcomes and personalized treatment approaches. Collaborative efforts among researchers, clinicians, and patients are essential to accelerate progress in thymus cancer research and develop more effective therapies for this challenging disease.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China